ADP-Ribosylation of Cytidine: A Novel Nucleic Acid Modification Reversed by NADAR Hydrolases
ADP-ribosylation of nucleic acids is a modification found in both eukaryotes and bacteria, where it contributes to genome maintenance but can also serve as a toxic mechanism used by bacterial toxins to disrupt essential cellular processes. This modification is catalysed by ADP-ribosyltransferases and can be reversed by antagonistic ADP-ribosylgylcohydrolase enzymes. To date, ADP-ribosylation of nucleic acid bases has been described only for adenosine, guanosine, and thymidine. Here we report the ADP-ribosylation of cytidine, catalysed by members of the pierisin family of bacterial toxins-ScARP (SCO5461) and Scabin. We also show that ADP-ribosylation of cytidine is reversible through removal by certain NADAR family proteins, including NADAR proteins from the bacterium <i>Streptomyces coelicolor</i> (SCO5665) and the sponge <i>Amphimedon queenslandica</i>, as well as YbiA-type NADAR proteins. The conservation of cytidine de-ADP-ribosylating activity of NADAR proteins across phylogenetically distant species suggests that this modification may have important physiological significance.
Authors
- Andrea Hloušek-Kasun (ORCID: https://orcid.org/0000-0002-7909-9300)
- Andreja Mikoč
- Marion Schüller
- Petra Mikolčević (ORCID: https://orcid.org/0009-0001-0125-3611)
- Ivan Ahel
- Elena Pirović
- Yang Lu
Institutions
- University of Graz (AT)
- University of Oxford (GB)
- Ruđer Bošković Institute (HR)
- Max Planck Institute of Biochemistry (DE)
Publication Details
- Journal
- Toxins
- Published
- 2026-02-06
- DOI
- https://doi.org/10.3390/toxins18020082
- Primary Topic
- PARP inhibition in cancer therapy
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Wellcome Trust
- Cancer Research UK
- European Commission
- Directorate for Biological Sciences